GB9412995D0 - Safety enhancing pharmaceutical compositions of an active indazole - Google Patents

Safety enhancing pharmaceutical compositions of an active indazole

Info

Publication number
GB9412995D0
GB9412995D0 GB9412995A GB9412995A GB9412995D0 GB 9412995 D0 GB9412995 D0 GB 9412995D0 GB 9412995 A GB9412995 A GB 9412995A GB 9412995 A GB9412995 A GB 9412995A GB 9412995 D0 GB9412995 D0 GB 9412995D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
safety enhancing
enhancing pharmaceutical
indazole
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB9412995A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
REDPATH TREVOR H
Original Assignee
REDPATH TREVOR H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by REDPATH TREVOR H filed Critical REDPATH TREVOR H
Priority to GB9412995A priority Critical patent/GB9412995D0/en
Publication of GB9412995D0 publication Critical patent/GB9412995D0/en
Priority to GB9822737A priority patent/GB2327191A/en
Priority to GB9507929A priority patent/GB2291591A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB9412995A 1994-06-28 1994-06-28 Safety enhancing pharmaceutical compositions of an active indazole Pending GB9412995D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB9412995A GB9412995D0 (en) 1994-06-28 1994-06-28 Safety enhancing pharmaceutical compositions of an active indazole
GB9822737A GB2327191A (en) 1994-06-28 1995-04-19 Pharmaceutical uses of granisetron
GB9507929A GB2291591A (en) 1994-06-28 1995-04-19 Pharmaceutical uses of granisetron

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9412995A GB9412995D0 (en) 1994-06-28 1994-06-28 Safety enhancing pharmaceutical compositions of an active indazole

Publications (1)

Publication Number Publication Date
GB9412995D0 true GB9412995D0 (en) 1994-10-26

Family

ID=10757464

Family Applications (2)

Application Number Title Priority Date Filing Date
GB9412995A Pending GB9412995D0 (en) 1994-06-28 1994-06-28 Safety enhancing pharmaceutical compositions of an active indazole
GB9507929A Withdrawn GB2291591A (en) 1994-06-28 1995-04-19 Pharmaceutical uses of granisetron

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB9507929A Withdrawn GB2291591A (en) 1994-06-28 1995-04-19 Pharmaceutical uses of granisetron

Country Status (1)

Country Link
GB (2) GB9412995D0 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1161118C (en) * 1998-12-22 2004-08-11 诺瓦提斯药物有限公司 Use of 5HT3 receptor antagouists for the treatment of chronic fatigue syndrome
US20050042194A1 (en) 2000-05-11 2005-02-24 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
US20110288115A1 (en) * 2010-05-24 2011-11-24 Avmedis Llc Treatment of vagally-mediated spectrum disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0498466B1 (en) * 1985-04-27 2002-07-24 F. Hoffmann-La Roche Ag Indazole-3-carboxamide and -3-carboxylic acid derivatives
EP0551963A3 (en) * 1986-12-17 1993-09-01 Glaxo Group Limited Use of heterocyclic derivatives for the manufacture of medicaments
GB9305593D0 (en) * 1993-03-18 1993-05-05 Smithkline Beecham Plc Pharmaceuticals

Also Published As

Publication number Publication date
GB9507929D0 (en) 1995-06-14
GB2291591A (en) 1996-01-31

Similar Documents

Publication Publication Date Title
IL119078A (en) Substituted benzylaminopiperidine compounds and pharmaceutical compositions comprising them
ZA965866B (en) 6-Dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
ZA9610650B (en) 1-Phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
HUP9601566A2 (en) Therapeutic tetrahydro-isoquinolin derivatives, their intermediates and pharmaceutical compositions containing the active component
IL114622A0 (en) Heteroaryl-oxazolidinones and pharmaceutical compositions containing them
GB9407386D0 (en) Pharmaceutical formulation
GB9402203D0 (en) Pharmaceutical formulation
IL112521A0 (en) Pharmaceutical formulation
HU9802795D0 (en) Pharmaceutical compositions containing more active components
HUP9700005A3 (en) 2-ureido-benzamide derivatives and pharmaceutical compositions containing them as active agent
HUT74746A (en) Pharmaceutical compositions containing p antagonist
IL113329A (en) Pharmaceutical compositions containing n-substituted benzamides
GB9405856D0 (en) Pharmaceutical formulation
GB9416599D0 (en) Pharmaceutical formulation
GB2331926B (en) Pharmaceutical compositions containing ibuprofen and domperidone for the treatment of migraine
GB9412995D0 (en) Safety enhancing pharmaceutical compositions of an active indazole
IL120005A (en) Pharmaceutical compositions for the treatment of the eye
GB2295825B (en) Pharmaceutical compositions
HU9302821D0 (en) Pharmaceutical compositions containing 3-substituted-2-oxindole-1-carboxamide as medical agent
GB9822734D0 (en) Safety enhancing pharmaceutical compositions
GB9400047D0 (en) Pharmaceutical compositions
GB2285923B (en) Pharmaceutical compositions containing N-acetal-cysteine
IL118384A0 (en) Benzimidazole derivatives and pharmaceutical compositions containing them
GB2308545A (en) Pharmaceutical compositions
HUP9901162A3 (en) Compounds and compositions for delivering active agents